{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:27:55Z","timestamp":1778495275715,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006529","name":"Race and Difference Initiative, Emory University","doi-asserted-by":"publisher","award":["REB 23-5976"],"award-info":[{"award-number":["REB 23-5976"]}],"id":[{"id":"10.13039\/100006529","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ard.2025.01.007","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T04:35:38Z","timestamp":1738816538000},"page":"584-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis"],"prefix":"10.1016","volume":"84","author":[{"given":"Patricia","family":"Remalante-Rayco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel S","family":"Baja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Baskurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Chim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Irwin A","family":"Panelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Osio-Salido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Inman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonila F","family":"Dans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ard.2025.01.007_bib0001","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.40750","article-title":"Sacroiliac joint ankylosis in young spondyloarthritis patients receiving biologic therapy: observation of serial magnetic resonance imaging scans","volume":"71","author":"Bray","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.01.007_bib0002","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/annrheumdis-2017-212377","article-title":"Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial","volume":"77","author":"van der Heijde","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.01.007_bib0003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/1744666X.2018.1477591","article-title":"Radiographic progression in non-radiographic axial spondyloarthritis","volume":"14","author":"Protopopov","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"7","key":"10.1016\/j.ard.2025.01.007_bib0004","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/art.40475","article-title":"Magnetic resonance imaging of the sacroiliac joints indicating sacroiliitis according to the assessment of spondyloarthritis international society definition in healthy individuals, runners, and women with postpartum back pain","volume":"70","author":"de Winter","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.01.007_bib0005","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1136\/annrheumdis-2011-200025","article-title":"HLA-B27 and gender independently determine the likelihood of a positive MRI of the sacroiliac joints in patients with early inflammatory back pain: a 2-year MRI follow-up study","volume":"70","author":"van Onna","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.01.007_bib0006","series-title":"2016 ACR\/ARHP Annual Meeting: Arthritis Rheumatol","article-title":"In contrast to men, women with nonradiographic axial spondyloarthritis have lower response rates to TNF inhibitors than women with ankylosing spondylitis [abstract]","author":"Ciurea","year":"2016"},{"issue":"8","key":"10.1016\/j.ard.2025.01.007_bib0007","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/rheumatology\/keab901","article-title":"Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results","volume":"61","author":"Poddubnyy","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ard.2025.01.007_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001108","article-title":"Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis","volume":"5","author":"L\u00f3pez-Medina","year":"2019","journal-title":"RMD Open"},{"issue":"10089","key":"10.1016\/j.ard.2025.01.007_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ard.2025.01.007_bib0010","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3899\/jrheum.130588","article-title":"Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?","volume":"40","author":"Wallis","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.01.007_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","article-title":"Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study","volume":"73","author":"Landew\u00e9","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.01.007_bib0012","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2012-202389","article-title":"Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial","volume":"72","author":"Song","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2025.01.007_bib0013","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"suppl 9","key":"10.1016\/j.ard.2025.01.007_bib0014","article-title":"Females with non-radiographic but not with radiographic axial spondyloarthritis are less likely to achieve inactive disease state than males: results from a multicountry prospective observational study","volume":"74","author":"Poddubnyy","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.01.007_bib0015","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/rheumatology\/keae088","article-title":"Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials","volume":"63","author":"Xie","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.ard.2025.01.007_bib0016","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/aje\/kwg074","article-title":"Estimating the relative risk in cohort studies and clinical trials of common outcomes","volume":"157","author":"McNutt","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ard.2025.01.007_bib0017","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"30","key":"10.1016\/j.ard.2025.01.007_bib0018","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1002\/sim.7059","article-title":"Prevalence odds ratio versus prevalence ratio: choice comes with consequences","volume":"35","author":"Tamhane","year":"2016","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.ard.2025.01.007_bib0019","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.ard.2025.01.007_bib0020","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019","volume":"45","author":"Textor","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.ard.2025.01.007_bib0021","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ije\/dyr218","article-title":"Recommendations for presenting analyses of effect modification and interaction","volume":"41","author":"Knol","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.ard.2025.01.007_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"key":"10.1016\/j.ard.2025.01.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.simpa.2021.100147","article-title":"InteractionR: an R package for full reporting of effect modification and interaction","volume":"10","author":"Alli","year":"2021","journal-title":"Software Impacts"},{"issue":"4","key":"10.1016\/j.ard.2025.01.007_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ard.2025.01.007_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jclinepi.2023.09.014","article-title":"The use of the E-value for sensitivity analysis","volume":"163","author":"Chung","year":"2023","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ard.2025.01.007_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ard.2025.01.007_bib0027","series-title":"IVEware: Imputation and Variance Estimation Software","author":"Raghunathan","year":"2022"},{"issue":"3","key":"10.1016\/j.ard.2025.01.007_bib0028","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"issue":"7","key":"10.1016\/j.ard.2025.01.007_bib0029","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/annrheumdis-2012-201933","article-title":"Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor alpha inhibitor therapy: results from the Danish nationwide DANBIO registry","volume":"72","author":"Glintborg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.01.007_bib0030","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/1756-185X.13271","article-title":"Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice","volume":"21","author":"Rusman","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.01.007_bib0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","article-title":"Gender differences in axial spondyloarthritis: women are not so lucky","volume":"20","author":"Rusman","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1016\/j.ard.2025.01.007_bib0032","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/annrheumdis-2019-215427","article-title":"Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration","volume":"78","author":"\u00d8rnbjerg","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.01.007_bib0033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3899\/jrheum.160958","article-title":"Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status. An observational cohort study from the nationwide DANBIO registry","volume":"44","author":"Glintborg","year":"2017","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2025.01.007_bib0034","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1093\/rheumatology\/keab070","article-title":"Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry","volume":"60","author":"Michelena","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.01.007_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13075-020-02337-2","article-title":"Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort","volume":"22","author":"Neuenschwander","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.ard.2025.01.007_bib0036","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/acr.22001","article-title":"Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort","volume":"65","author":"Tournadre","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.ard.2025.01.007_bib0037","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.01.007_bib0038","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/art.39257","article-title":"A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis","volume":"67","author":"Sieper","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.ard.2025.01.007_bib0039","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.38721","article-title":"Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dougados","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2025.01.007_bib0040","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1093\/rheumatology\/keaa900","article-title":"Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS","volume":"60","author":"Zhao","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 1","key":"10.1016\/j.ard.2025.01.007_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000053","article-title":"Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?","volume":"1","author":"Baraliakos","year":"2015","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.ard.2025.01.007_bib0042","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","article-title":"Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?","volume":"64","author":"Kiltz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.ard.2025.01.007_bib0043","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","article-title":"Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group","volume":"75","author":"Lambert","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ard.2025.01.007_bib0044","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.21445","article-title":"Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis","volume":"53","author":"Maksymowych","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:02:30Z","timestamp":1744243350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0003496725000524"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.01.007","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}